Status:
COMPLETED
Sequential and Mixture Injection of Opioids and Hyperbaric Bupivacaine
Lead Sponsor:
Assiut University
Conditions:
Bupivacaine Adverse Reaction
Regional Anesthesia Morbidity
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Neuraxial anesthesia, especially the subarachnoid block, is the preferred method for LSCS. The intrathecal spread of local anesthetic drugs is unpredictable. However, Baricity, which is the relative d...
Eligibility Criteria
Inclusion
- LSCS
- ASA I or II
- Single baby pregnancy of more than 32 weeks
- Elective or semi-elective surgery (category 3 and 4 Caesarean sections)
Exclusion
- Abnormal Placentation
- PET
- Disordered coagulation
- Allergy to opioids or local anesthetic.
- BMI \> 35
- Spine surgery
- Cardiac disease
- Extremes of height; height more than 180 or less than 140
- Multiple pregnancy or polyhydramnios
Key Trial Info
Start Date :
July 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2021
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04403724
Start Date
July 11 2020
End Date
March 17 2021
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University hospital
Asyut, Egypt, 11111